FTC approves Merck & Co/Schering-Plough merger
This article was originally published in Scrip
Executive Summary
Merck & Co's $41.1 billion merger with Schering-Plough has been approved by the US FTC after the organisation ruled that the companies' sale of certain assets would satisfy its concerns regarding the deal's potential anti-competitive effects.